Select Your Best Downstream Process Intensification Strategy With The ExCIT Tool

The monoclonal antibody (mAb) industry is evolving rapidly, with intensified processing emerging as a key strategy to meet growing demand while reducing costs and environmental impact. By modeling every chromatography step, manufacturers can pinpoint the most efficient media, optimal intensification levels, and total cost of ownership. Connected downstream processing offers even greater benefits, boosting productivity, minimizing buffer use, and eliminating bottlenecks that slow production. These approaches not only streamline operations but also help future-proof facilities against market shifts.

Learn how to secure a competitive edge through smarter chromatography strategies and continuous processing innovations that deliver measurable gains in efficiency and sustainability.